%Responders to VATREPTACOG in the cohort (WORLD):
by Thymidine Incorporation (95% CI): %67.6056 (63.1455,71.831)
by IL-2 ELISpot (95% CI): %32.6291 (28.169,37.0892)
by Combined Thymidine Incorporation & IL-2 ELISpot (95% CI): %32.3944 (28.169,36.8545)
--
%Similarity between Thymidine Incorporation & IL-2 ELISpot predictions (95% CI): %64.7418 (59.7676,69.716)
